y 590 has been researched along with bemoradan in 1 studies
| Studies (y 590) | Trials (y 590) | Recent Studies (post-2010) (y 590) | Studies (bemoradan) | Trials (bemoradan) | Recent Studies (post-2010) (bemoradan) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 8 | 0 | 0 |
| Protein | Taxonomy | y 590 (IC50) | bemoradan (IC50) |
|---|---|---|---|
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 0.3 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 0.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Combs, DW; Demers, JP; Falotico, R; Moore, JB; Rampulla, MS | 1 |
1 other study(ies) available for y 590 and bemoradan
| Article | Year |
|---|---|
Heteroatom analogues of bemoradan: chemistry and cardiotonic activity of 1,4-benzothiazinylpyridazinones.
Topics: Animals; Benzoxazines; Cardiotonic Agents; Dogs; Heart; Myocardium; Oxazines; Pyridazines; Structure-Activity Relationship | 1992 |